L-18F-FAC
N/A
Report date: 2025/11/24 17:27:46
Base Information
Drug NameL-18F-FAC
Drug Alias Name
Classification +[5]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusDiscontinued (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNew York UniversityNederlands Kanker InstituutUniversity Of California At Los Angeles
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesUniversity Of California At Los AngelesNederlands Kanker InstituutNew York University
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A